Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group.

European Journal of Cancer & Clinical Oncology
T PopielaF Giongo

Abstract

A total of 173 female terminal cancer patients were randomized to treatment with daily 125 mg infusions of methylprednisolone sodium succinate or a matching placebo for a period of 8 consecutive weeks. Data were collected relative to quality of life, investigator assessment of efficacy and cause and time of death within the 8-week treatment period. Significant improvement in quality of life was reported across the 8-week follow-up period in the steroid group. Investigator global assessment of efficacy significantly favored the steroid-treatment patients. There were no significant differences between treatment groups with regard to overall mortality rates or time to death. The total number of reported adverse events did not differ significantly between treatment groups. However, significantly more steroid patients reported gastrointestinal and cardiovascular events. The severity and outcome of these events did not differ from the placebo patients. The results of this study confirm previous reports of steroid efficacy in improving quality of life in terminal cancer patients. The absence of any untoward effect on mortality and the favorable safety profile support the use of methylprednisolone as palliative therapy for terminal can...Continue Reading

Citations

Nov 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·E Bruera
Mar 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C L Loprinzi
Apr 22, 2005·Reviews in Endocrine & Metabolic Disorders·David R Thomas
May 31, 2012·Current Pain and Headache Reports·Wojciech Leppert, Tomasz Buss
Sep 1, 1996·Journal of Pain and Symptom Management·H YanagawaS Sone
Nov 30, 2002·Journal of Pain and Symptom Management·Sussanne BörjesonGunnar Steineck
Feb 1, 1996·Nutrition·C R Plata-Salamán
Sep 24, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G WestmanP Orgum
Dec 13, 2000·Surgical Oncology·M D BarberK C Fearon
Nov 5, 2002·Nature Reviews. Cancer·Michael J Tisdale
Apr 25, 2006·Journal of Palliative Medicine·Egidio Del FabbroEduardo Bruera
Aug 27, 2013·Drug Design, Development and Therapy·Giovanni MantovaniAntonio Macciò
Aug 4, 2011·Indian Journal of Palliative Care·Maryann MuckadenSavita Goswami
Jun 1, 1996·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D B GoughO Eremin
Apr 8, 2014·Journal of Palliative Medicine·Sarah MillerNoleen McCorry
Oct 7, 2004·Cancer·Karsten MünstedtRichard von Georgi
Apr 9, 2005·Seminars in Oncology·Jamie H Von Roenn, Judith A Paice
Jul 19, 2003·Journal of Chemotherapy·G LelliD Scapoli
Jun 27, 2015·The Journal of Endocrinology·Maria Carolina S MendesJosé B C Carvalheira
Oct 18, 2012·Expert Opinion on Pharmacotherapy·Antonio MacciòGiovanni Mantovani
May 23, 2007·Expert Opinion on Pharmacotherapy·Deepti Behl, Aminah Jatoi
Mar 10, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·B AfsharimaniJ Hardy
Dec 17, 2014·Nutrition and Cancer·Patrizia MondelloVincenzo Pitini
May 24, 2006·Journal of Pain and Symptom Management·Lea Renina LlanesSharon Watanabe
Dec 7, 2006·Pain Practice : the Official Journal of World Institute of Pain·S K ReddyN Gouondraj
Jun 9, 2006·Acta Oncologica·Staffan H Lundström, Carl Johan Fürst
Jan 28, 2006·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·David R Thomas
Apr 17, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Esther Uña Cidón
Jan 25, 2008·Palliative Medicine·Lukas RadbruchUNKNOWN Research Steering Committee of the European Association for Palliative Care (EAPC)
Aug 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian E Haines, Robert M Stanley
Jul 9, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ornulf PaulsenStein Kaasa
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tugba YavuzsenRuth Lagman
May 7, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Janette Vardy, Meera Agar
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian E Haines
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hendrik J AgtereschPieter C Dagnelie
Feb 21, 2006·Journal of Pain and Symptom Management·Emma ReamCaroline Alexander-Dann
Jun 30, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yen-Shen LuAnn-Lii Cheng
Mar 19, 2014·Head & Neck·Marion E CouchHirak Der-Torossian
Oct 7, 2003·Palliative Medicine·Staffan Lundström, Carl Johan Fürst

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.